{"id":9087,"date":"2025-10-15T16:59:09","date_gmt":"2025-10-15T14:59:09","guid":{"rendered":"https:\/\/bioib.org\/uncategorized\/acesabio-is-hosting-a-strategic-meeting-at-biospain2025-to-promote-a-common-agenda-and-strengthen-territorial-scientific-and-industrial-cooperation-among-spanish-health-clusters\/"},"modified":"2026-11-16T19:45:22","modified_gmt":"2026-11-16T18:45:22","slug":"acesabio-is-hosting-a-strategic-meeting-at-biospain2025-to-promote-a-common-agenda-and-strengthen-territorial-scientific-and-industrial-cooperation-among-spanish-health-clusters","status":"publish","type":"post","link":"https:\/\/bioib.org\/en\/news\/acesabio-is-hosting-a-strategic-meeting-at-biospain2025-to-promote-a-common-agenda-and-strengthen-territorial-scientific-and-industrial-cooperation-among-spanish-health-clusters\/","title":{"rendered":"ACESABIO is hosting a strategic meeting at BioSpain2025 to promote a common agenda and strengthen territorial, scientific, and industrial cooperation among Spanish health clusters"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><\/p>\n\n<p class=\"wp-block-paragraph\">The participation of the <strong>Alliance of Spanish Health Clusters (ACESABIO) at <\/strong>BioSpain\u2014which brings together 12 regional clusters from 10 autonomous communities and represents more than 1,050 entities\u2014provided new momentum to consolidate the health sector as <strong>a driver of knowledge, innovation, and economic specialization.<\/strong><\/p>\n\n<ul class=\"wp-block-list\">\n<li><strong>The Balearic Islands<\/strong> are part of the Alliance of Spanish Health Clusters through the <strong>Biotechnology and Biomedical Cluster (BIOIB)<\/strong>, represented by its manager, Zara Pons.<\/li>\n<\/ul>\n\n<ul class=\"wp-block-list\">\n<li>ACESABIO reaffirmed its commitment to <strong>engaging with the key issues at the heart of the European regulatory debate on health<\/strong>, contributing from a technical and coordinated perspective within the sector, so that adaptation to new regulations keeps pace with innovation.<\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\"><strong>Barcelona, October 10, 2025<\/strong>.\u2014The <strong>Alliance of Spanish Health Clusters (ACESABIO)<\/strong> participated in the <strong>12th edition of BioSpain,<\/strong> the leading national event and one of Europe\u2019s premier forums on biotechnology and life sciences, which brought together more than 2,000 professionals and representatives from 30 countries in Barcelona from October 7 to 9.<\/p>\n\n<p class=\"wp-block-paragraph\">The conference focused on <strong>innovation, <\/strong> <strong>sustainability, and <\/strong><strong> artificial intelligence applied to healthcare<\/strong> as the pillars of a new era for the sector, aimed at strengthening Europe\u2019s strategic autonomy and consolidating a more competitive economic and healthcare model. The program also addressed key issues such as investment and international partnerships, training and attracting specialized talent, and the European regulatory challenges that determine <strong>innovation\u2019s access to the market<\/strong>. <\/p>\n\n<p class=\"wp-block-paragraph\">In this context, the <strong>role of biotechnology as a driver of industrial and healthcare transformation<\/strong> was emphasized, as was the need to strengthen the connection between science, business, and investment to accelerate knowledge transfer and the development of new biomedical solutions. In this regard, <strong>health clusters<\/strong>, represented by<strong> ACESABIO<\/strong>, play an essential coordinating role, acting as <strong>hubs for regional cooperation<\/strong> that help consolidate an innovative, cohesive, and competitive biohealth ecosystem, poised to lead an <strong>unprecedented transformation in the sector\u2019s future.<\/strong> <\/p>\n\n<p class=\"wp-block-paragraph\">During the meeting, <strong>ACESABIO<\/strong> held a working session in which it defined the <strong>strategic lines of collaboration<\/strong> for the coming years. Among its priority objectives are strengthening interregional cooperation among Spanish health clusters, promoting innovation, and consolidating the sector\u2019s position as a driver of economic growth and knowledge generation. <\/p>\n\n<p class=\"wp-block-paragraph\">Representatives from the leading regional clusters, such as <strong>Zara Pons, manager of the Balearic Islands Biotechnology and Biomedical Cluster (BIOIB)<\/strong>, emphasized that biotechnology and innovation in health are undergoing <strong>a period of maturity and sustained growth<\/strong> in Spain. To reinforce this trend, ACESABIO is committed to strengthening collaboration among autonomous communities by organizing joint initiatives that enhance the competitiveness and international visibility of the biotech and healthcare ecosystem. <\/p>\n\n<p class=\"wp-block-paragraph\">The alliance maintains an <strong>active presence in European regulatory debates<\/strong>, advocating for constructive and coordinated dialogue with the relevant authorities to ensure a streamlined, transparent, and innovation-friendly environment. In this regard, the health clusters emphasized the need to <strong>align common positions on strategic issues, such <\/strong>as the <em>Notified Bodies.<\/em> <\/p>\n\n<p class=\"wp-block-paragraph\">ACESABIO welcomed the recent designation of the National Center for the Certification of Medical Devices (CNCps) under the IVDR Regulation and emphasized the need to <strong>strengthen national certification capacity and maintain an open dialogue with the authorities to <\/strong>facilitate market access and support the sector\u2019s growth. <\/p>\n\n<p class=\"wp-block-paragraph\">Another priority area for the alliance is <strong>specialized training and attracting talent<\/strong>, both of which are essential for strengthening human capital and improving the sector\u2019s competitiveness. Likewise, ACESABIO committed to promoting the use of <strong>collaborative technology platforms<\/strong> that keep <strong>the Spanish biotech community interconnected<\/strong>, fostering cooperation among regions, research centers, companies, and government agencies, and promoting the exchange of knowledge, projects, and opportunities. <\/p>\n\n<p class=\"wp-block-paragraph\">With plans to expand into new communities and a shared work agenda, ACESABIO is establishing itself as a <strong>national platform for cooperation<\/strong> aimed at promoting innovation, knowledge transfer, and improving the competitiveness of the biopharmaceutical sector in Spain and Europe.<\/p>\n\n<p class=\"wp-block-paragraph\"><strong>About ACESABIO<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">Officially established in late 2023, <strong>ACESABIO<\/strong> brings together <strong>12 regional<\/strong> health and biosciences <strong>clusters<\/strong> representing <strong>10 autonomous communities<\/strong>:<br\/>, Arahealth (Arag\u00f3n), Basque Health Cluster (Basque Country), BIOIB (Balearic Islands), Bioga (Galicia), Bioval (Valencian Community), Catalonia Health (Catalonia), the Extremadura Social and Health Cluster, Cl\u00faster Sa\u00fade de Galicia (Galicia), Navarra Health Cluster (Navarra), Cl\u00faster SIVI (Castile and Le\u00f3n), Ticbiomed (Murcia), and WeMind Cluster (Catalonia).<\/p>\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"960\" height=\"539\" src=\"https:\/\/bioib.org\/wp-content\/uploads\/2025\/10\/image-3.png\" alt=\"\" class=\"wp-image-7983\" srcset=\"https:\/\/bioib.org\/wp-content\/uploads\/2025\/10\/image-3.png 960w, https:\/\/bioib.org\/wp-content\/uploads\/2025\/10\/image-3-300x168.png 300w, https:\/\/bioib.org\/wp-content\/uploads\/2025\/10\/image-3-768x431.png 768w\" sizes=\"(max-width: 960px) 100vw, 960px\" \/><\/figure>\n\n<p class=\"wp-block-paragraph\">Overall, ACESABIO represents 1,050 entities, including SMEs (73%), startups (18%), corporations (15%), knowledge centers, and patient associations, with an aggregate revenue exceeding 27,000 million euros and more than 378,000 direct jobs. This breadth gives it a<strong>unique<\/strong> <strong>level of representativeness<\/strong><strong>in the sector<\/strong> and makes it a <strong>key partner  for <\/strong> promoting R&amp;D&amp;I and interregional collaboration.The Alliance actively works to improve the competitiveness of companies in the sector, promote knowledge transfer, and foster collaboration among science, business, government, and civil society under the quadruple helix model. Finally, BIOIB and a delegation from the Balearic Islands Government\u2019s Department of Health, represented by Gema Jim\u00e9nez, head of the Health Research Service, and Adri\u00e1n Fern\u00e1ndez, an IB-Salut physician specializing in AI, toured the fair together, visiting the most innovative digital health exhibits and exchanging views on the future of healthcare.   <\/p>\n\n<figure class=\"wp-block-gallery has-nested-images columns-default is-cropped wp-block-gallery-1 is-layout-flex wp-block-gallery-is-layout-flex\"><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>The participation of the Alliance of Spanish Health Clusters (ACESABIO) at BioSpain\u2014which brings together 12 regional clusters from 10 autonomous communities and represents more than 1,050 entities\u2014provided new momentum to consolidate the health sector as a driver of knowledge, innovation, and economic specialization. Barcelona, October 10, 2025.\u2014The Alliance of Spanish Health Clusters (ACESABIO) participated in [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":7984,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[38],"tags":[],"class_list":["post-9087","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/bioib.org\/en\/wp-json\/wp\/v2\/posts\/9087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioib.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioib.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioib.org\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/bioib.org\/en\/wp-json\/wp\/v2\/comments?post=9087"}],"version-history":[{"count":1,"href":"https:\/\/bioib.org\/en\/wp-json\/wp\/v2\/posts\/9087\/revisions"}],"predecessor-version":[{"id":9088,"href":"https:\/\/bioib.org\/en\/wp-json\/wp\/v2\/posts\/9087\/revisions\/9088"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bioib.org\/en\/wp-json\/wp\/v2\/media\/7984"}],"wp:attachment":[{"href":"https:\/\/bioib.org\/en\/wp-json\/wp\/v2\/media?parent=9087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioib.org\/en\/wp-json\/wp\/v2\/categories?post=9087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioib.org\/en\/wp-json\/wp\/v2\/tags?post=9087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}